/cdn.vox-cdn.com/uploads/chorus_image/image/67467134/1228676093.jpg.0.jpg)
When the season was getting started and the pandemic was still at a high point in this country, one of the main concerns was that MLB would be taking tests from the public. The league, in turn, said they’d provide tests to the public. As it turns out, only the Red Sox have held up their end of the bargain. And even they are way late to coming through. (Bradford William Davis; New York Post)
One of the few positives of this season for the Red Sox has been Alex Verdugo and his performance that has put him firmly in the core moving forward. (Alex Speier; Boston Globe)
Chad Jennings outlines the massive changes undergone by this Red Sox roster, even in a shortened season. (Chad Jennings; The Athletic)
Amid those changes, there’s actually some mild optimism about the rotation next year. (Sean McAdam; Boston Sports Journal)
Part of that is because Nathan Eovaldi pitched so well to close things out. And after that finish, John Tomase says the Red Sox would be wise to sell high. (John Tomase; NBC Sports Boston)
Chris Sale should be around at some point next year, too, though he still has a ways to go. (Jason Mastrodonato; Boston Herald)
Rob Bradford thinks Rafael Devers should have gotten some time across the diamond this year. (Rob Bradford; WEEI)